FiercePharmaAsia—Indian generics contenders; Chi-Med’s HK listing; Qilu Pharma explosion

A group of six generics makers led by Indian firms have surpassed traditional suppliers led by Teva, Mylan and Novartis’ Sandoz in terms of weekly U.S. generics prescriptions. Chi-Med has filed to list on Hong Kong’s stock exchange on the back of positive regulatory and development news. A multiple-time pharma manufacturing safety offender saw an explosion… Read More »

Federal judge scolds Purdue, Endo and Mallinckrodt for stall tactics in opioids case

U.S. District Judge Dan Polster has had enough of opioids makers Purdue Pharma, Endo and Mallinckrodt asking for extensions in the multistate lawsuit against them. And he said as much Thursday in the Cleveland court where the case is being tried. Lawyers representing the companies and other defendants in the case had filed an emergency… Read More »